A CRISPR/Cas9 genome editing pipeline in the EndoC-βH1 cell line to study genes implicated in beta cell function is a research paper published in Wellcome Open Research (2020). On theSindex it has a DataRank of 0. It has been cited 22 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Medical Research Council
Grant: MR/L020149/1
Defining the molecular and physiological mechanisms of pancreatic islet dysfunction which lead to type 2 diabetes
Wellcome Trust
Grant: 200837
Defining mechanisms for pancreatic beta-cell dysfunction in type 2 diabetes
Wellcome Trust
Grant: 095101
Bridging the gap from type 2 diabetes genetics to functional mechanisms of disease.
National Institutes of Health
Grant: U01-DK105535
National Institutes of Health
Grant: U01-DK085545
Wellcome Trust
Grant: 200837/Z/16/Z
NIDDK NIH HHS
Grant: U01 DK085545
NIDDK NIH HHS
Grant: U01 DK105535
Wellcome Trust
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5U01DK085545-02
Identifying variants causal for Type 2 Diabetes in Major human populations
National Institutes of Health
Grant: 7U01DK105535-06
Integrating genome-scale data to reveal causal mechanisms in type 2 diabetes
Horizon 2020
NIHR Oxford Biomedical Research Centre
FWCI
1.42
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals